These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14318777)

  • 1. STUDIES ON IMMUNOGENICITY OF SAL. ABORTUS-EQUI BACTERIN. II.
    UEDA S; MATSUMOTO K; SOEKAWA M
    Kitasato Arch Exp Med; 1963 Dec; 36():13-26. PubMed ID: 14318777
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES ON IMMUNOGENICITY OF SAL. ABORTUS-EQUI BACTERIN. I. COMPARISON ON PROTECTIVE POTENCY OF THE BACTERINS OF CHROME ALUM-TREATED, POTASSIUM ALUM-TREATED, OIL-TREATED AND OF PLAIN.
    UEDA S; MATSUMOTO K; SOEKAWA M
    Kitasato Arch Exp Med; 1963 Dec; 36():1-11. PubMed ID: 14318778
    [No Abstract]   [Full Text] [Related]  

  • 3. [New aspects of infection of Equidae by Salmonella abortus equi].
    PERRIN G; SAURAT P; VERGE J
    Rec Med Vet Ec Alfort; 1950 Jun; 126(6):321-8. PubMed ID: 15430619
    [No Abstract]   [Full Text] [Related]  

  • 4. A new Montanide™ Seppic IMS1313-adjuvanted autogenous vaccine as a useful emergency tool to resolve a
    Stazi M; Pellegrini M; Rampacci E; Sforna M; Passamonti F; Di Paolo A; Severi G
    Open Vet J; 2022; 12(2):303-307. PubMed ID: 35603068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the immunogenicity of Streptococcus equi vaccines in foals.
    Srivastava SK; Barnum DA
    Can J Comp Med; 1985 Oct; 49(4):351-6. PubMed ID: 4075235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the agglutination of Salmonella abortus-equi. I. A comparison of the agglutinative activity between S. abortus-equi and the other B-group Salmonella].
    MATSUI K
    Nihon Saikingaku Zasshi; 1961 Jun; 16():516-20. PubMed ID: 13768221
    [No Abstract]   [Full Text] [Related]  

  • 7. A note of Salmonella abortus-equi infection in man.
    BRUNER DW
    J Bacteriol; 1946 Jul; 52():147. PubMed ID: 20994885
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of large plasmids encoding resistance to toxic heavy metals in Salmonella abortus equi.
    Ghosh A; Singh A; Ramteke PW; Singh VP
    Biochem Biophys Res Commun; 2000 May; 272(1):6-11. PubMed ID: 10872795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the agglutination of Salmonella abortus equi. II. Research on a factor influencing agglutinative activity].
    MATSUI K
    Nihon Saikingaku Zasshi; 1961 Sep; 16():777-80. PubMed ID: 14471265
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunogenicity of attenuated Salmonella choleraesuis vaccine strain expressing immunogenic genes of Mycoplasma hyopneumoniae in mice].
    Ma F; Zou H; He Q
    Wei Sheng Wu Xue Bao; 2011 Sep; 51(9):1270-7. PubMed ID: 22126084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study on the immunogenicity of live and inactivated Salmonella typhimurium vaccines in mice.
    Cameron CM; Fuls WJ
    Onderstepoort J Vet Res; 1974 Sep; 41(3):81-91. PubMed ID: 4620088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biological effects of a highly purified pyrogen (lipopolysaccaride) from Salmonella abortus equi].
    EICHENBERGER E; SCHMIDHAUSER-KOPP M; HURNI H; FRICSAY M; WESTPHAL O
    Schweiz Med Wochenschr; 1955 Dec; 85(50):1213-8; concl. PubMed ID: 13298649
    [No Abstract]   [Full Text] [Related]  

  • 13. Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection.
    Cardoso SA; Oliveira AF; Ruas LP; Trevisani MM; De Oliveira LL; Hanna ES; Roque-Barreira MC; Soares SG
    Vaccine; 2013 Sep; 31(41):4528-35. PubMed ID: 23933366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological effects of a highly purified pyrogen (lipopolysaccharide) from Salmonella abortus equi].
    EICHENBERGER E; SCHMIDHAUSER-KOPP M; HURNI H; FRICSAY M; WESTPHAL O
    Schweiz Med Wochenschr; 1955 Dec; 85(49):1190-6; contd. PubMed ID: 13298644
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model.
    Vanniasinkam T; Barton MD; Heuzenroeder MW
    Int J Med Microbiol; 2005 Jan; 294(7):437-45. PubMed ID: 15715172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of a live attenuated Salmonella vaccine strain expressing the VapA protein induces protection against infection by Rhodococcus equi.
    Oliveira AF; Ferraz LC; Brocchi M; Roque-Barreira MC
    Microbes Infect; 2007 Mar; 9(3):382-90. PubMed ID: 17307012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of calf age and Salmonella bacterin type on ability to produce immunoglobulins directed against Salmonella whole cells or lipopolysaccharide.
    Da Roden L; Smith BP; Spier SJ; Dilling GW
    Am J Vet Res; 1992 Oct; 53(10):1895-9. PubMed ID: 1456538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
    Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
    Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the safety and immunogenicity of Rhodococcus equi-secreted proteins combined with either a liquid nanoparticle (IMS 3012) or a polymeric (PET GEL A) water-based adjuvant in adult horses and foals--identification of promising new candidate antigens.
    Cauchard S; Bertrand F; Barrier-Battut I; Jacquet S; Laurentie M; Barbey C; Laugier C; Deville S; Cauchard J
    Vet Immunol Immunopathol; 2014 Feb; 157(3-4):164-74. PubMed ID: 24445196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhodococcus equi (Prescottella equi) vaccines; the future of vaccine development.
    Giles C; Vanniasinkam T; Ndi S; Barton MD
    Equine Vet J; 2015 Sep; 47(5):510-8. PubMed ID: 24945608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.